Quality by Design (QbD)

Abstract Ivermectin (IVM) is a widely used antiparasitic agent and has been repurposed for the treatment of COVID-19. However, its...

Abstract The main purpose of this study was to design and develop a solid self-nanoemulsifying drug delivery system (S-SNEDDS) for...

Abstract There is a significant deficiency of suitable pediatric medications, attributed to limited market, trial complexities, and strict regulatory requirements....

Abstract The current study presents a comprehensive pharmaceutical engineering approach to developing an advanced transdermal drug delivery system for addressing...

This paper covers a brief overview of the steps for pharmaceutical product development under the quality by design (QbD) framework;...

Abstract Ternary co-amorphous systems, comprising a drug, a low molecular weight co-former, and a polymer, are a promising approach to...

Introduction Neusilin Self-emulsifying drug delivery systems (SEDDS) have emerged as a promising approach for enhancing the oral bioavailability of challenging...

Purpose Understanding batch-to-batch variation of excipients and correlating this to process performance is a key concept of Quality-by-Design for pharmaceutical...

Itraconazole (ITZ), a BCS Class II drug exhibiting low solubility (1-4 ng/ mL in water) requires formulation enhancement to achieve...

Hydroxypropyl methylcellulose (HPMC) is a commonly used excipient to enable controlled release (CR) performance from a hydrophilic matrix tablet. Quality-by-Design...